{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:14:30Z","timestamp":1777644870456,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Clinical and Translational Science Institute"},{"name":"CTSI"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001881"],"award-info":[{"award-number":["UL1TR001881"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["R01-DK077162"],"award-info":[{"award-number":["R01-DK077162"]}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.xkme.2019.09.004","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T01:26:06Z","timestamp":1574731566000},"page":"20-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Equivalent Efficacy and Decreased Rate of Overcorrection in Patients With Syndrome of Inappropriate Secretion of Antidiuretic Hormone Given Very Low-Dose Tolvaptan"],"prefix":"10.1016","volume":"2","author":[{"given":"Ramy M.","family":"Hanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Velez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjay","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minhtri K.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad K.","family":"Kamgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyaw","family":"Moe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Arman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huma","family":"Hasnain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloofar","family":"Nobakht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umut","family":"Selamet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xkme.2019.09.004_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4158\/EP.12.4.446","article-title":"Hyponatremia, fluid-electrolyte disorders, and the syndrome of inappropriate antidiuretic hormone secretion: diagnosis and treatment options","volume":"12","author":"Siragy","year":"2006","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.xkme.2019.09.004_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5049\/EBP.2006.4.2.77","article-title":"Pseudohyponatremia: does it matter in current clinical practice?","volume":"4","author":"Kim","year":"2006","journal-title":"Electrolyte Blood Press"},{"issue":"8","key":"10.1016\/j.xkme.2019.09.004_bib3","first-page":"1056","article-title":"The hyponatremic patient: a systematic approach to laboratory diagnosis","volume":"166","author":"Milionis","year":"2002","journal-title":"CMAJ"},{"issue":"suppl 3","key":"10.1016\/j.xkme.2019.09.004_bib4","first-page":"S208","article-title":"Syndrome of inappropriate antidiuretic hormone secretion: revisiting a classical endocrine disorder","volume":"15","author":"Pillai","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.xkme.2019.09.004_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/2042018812437561","article-title":"Clinical management of SIADH","volume":"3","author":"Gross","year":"2012","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.xkme.2019.09.004_bib6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2215\/CJN.04431007","article-title":"Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone","volume":"3","author":"Decaux","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2019.09.004_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1024\/0040-5930.61.9.583","article-title":"[Serum concentration of uric acid, a diagnostic 'must' in\u00a0patients with hyponatremia]","volume":"61","author":"Frey","year":"2004","journal-title":"Ther Umsch"},{"issue":"728","key":"10.1016\/j.xkme.2019.09.004_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/pgmj.62.728.449","article-title":"Significance of the measurement of uric acid fractional clearance in diuretic induced hyponatraemia","volume":"62","author":"Sonnenblick","year":"1986","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.xkme.2019.09.004_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3121\/cmr.2007.762","article-title":"Tumor-related hyponatremia","volume":"5","author":"Onitilo","year":"2007","journal-title":"Clin Med Res"},{"issue":"11","key":"10.1016\/j.xkme.2019.09.004_bib10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/qjmed\/91.11.749","article-title":"Treating the syndrome of inappropriate ADH secretion with isotonic saline","volume":"91","author":"Musch","year":"1998","journal-title":"QJM"},{"issue":"11","key":"10.1016\/j.xkme.2019.09.004_bib11","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40264-015-0327-3","article-title":"Clinical pattern of tolvaptan-associated liver injury in subjects with autosomal dominant polycystic kidney disease: analysis of clinical trials database","volume":"38","author":"Watkins","year":"2015","journal-title":"Drug Saf"},{"key":"10.1016\/j.xkme.2019.09.004_bib12","first-page":"807054","article-title":"Unpredictable nature of tolvaptan in treatment of hypervolemic hyponatremia: case review on role of vaptans","volume":"2014","author":"Malhotra","year":"2014","journal-title":"Case Rep Endocrinol"},{"issue":"2","key":"10.1016\/j.xkme.2019.09.004_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/MAJ.0000000000000324","article-title":"Risk factors, complication and measures to prevent or reverse catastrophic sodium overcorrection in chronic hyponatremia","volume":"349","author":"Gharaibeh","year":"2015","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.xkme.2019.09.004_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12902-017-0214-2","article-title":"In-patient tolvaptan use in SIADH: care audit, therapy observation and outcome analysis","volume":"17","author":"Humayun","year":"2017","journal-title":"BMC Endocr Disord"},{"issue":"12","key":"10.1016\/j.xkme.2019.09.004_bib15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/qjmed\/hcg159","article-title":"Osmotic demyelination syndrome: a potentially avoidable disaster","volume":"96","author":"Lin","year":"2003","journal-title":"QJM"},{"issue":"suppl 1","key":"10.1016\/j.xkme.2019.09.004_bib16","doi-asserted-by":"crossref","first-page":"P143","DOI":"10.1186\/cc10750","article-title":"Risk factors for poor outcome in patients with osmotic demyelination syndrome","volume":"16","author":"Peters","year":"2012","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.xkme.2019.09.004_bib17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/ckj\/sfw034","article-title":"The utility and accuracy of four equations in predicting sodium levels in dysnatremic patients","volume":"9","author":"Hanna","year":"2016","journal-title":"Clin Kidney J"},{"issue":"11","key":"10.1016\/j.xkme.2019.09.004_bib18","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1093\/ndt\/gfn476","article-title":"Can we really predict the change in serum sodium levels? An analysis of currently proposed formulae in hypernatraemic patients","volume":"23","author":"Lindner","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.xkme.2019.09.004_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/ckj\/sfw050","article-title":"Formulas for fixing serum sodium: curb your enthusiasm","volume":"9","author":"Sterns","year":"2016","journal-title":"Clin Kidney J"},{"issue":"6","key":"10.1016\/j.xkme.2019.09.004_bib20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1053\/j.ajkd.2017.12.002","article-title":"Rapidity of correction of hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone following tolvaptan","volume":"71","author":"Morris","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"suppl 3","key":"10.1016\/j.xkme.2019.09.004_bib21","first-page":"iii22","article-title":"Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes","volume":"75","author":"Martin","year":"2004","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.xkme.2019.09.004_bib22","first-page":"143","article-title":"Risk of serum sodium overcorrection with V2 antagonists in SIADH and other high risk patients","volume":"1","author":"Kamgar","year":"2017","journal-title":"J\u00a0Onconephrol"},{"issue":"4","key":"10.1016\/j.xkme.2019.09.004_bib23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2009080857","article-title":"Oral tolvaptan is safe and effective in chronic hyponatremia","volume":"21","author":"Berl","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2019.09.004_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nrneph.2010.61","article-title":"Hyponatremia: prolonged use of the vasopressin antagonist tolvaptan is a safe and effective treatment for hyponatremia","volume":"6","author":"Ireland","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"20","key":"10.1016\/j.xkme.2019.09.004_bib25","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.xkme.2019.09.004_bib26","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1681\/ASN.V481522","article-title":"Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective","volume":"4","author":"Sterns","year":"1994","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2019.09.004_bib27","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2215\/CJN.10440917","article-title":"Treatment of severe hyponatremia","volume":"13","author":"Sterns","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2019.09.004_bib28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-107-5-656","article-title":"Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases","volume":"107","author":"Sterns","year":"1987","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.xkme.2019.09.004_bib29","doi-asserted-by":"crossref","first-page":"537 e9","DOI":"10.1016\/j.amjmed.2015.11.005","article-title":"Diagnosing and treating the syndrome of inappropriate antidiuretic hormone secretion","volume":"129","author":"Verbalis","year":"2016","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.xkme.2019.09.004_bib30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3904\/kjim.2016.155","article-title":"Comparison of tolvaptan treatment between patients with the SIADH and congestive heart failure: a single-center experience","volume":"33","author":"Park","year":"2018","journal-title":"Korean J Intern Med"}],"updated-by":[{"DOI":"10.1016\/j.xkme.2020.03.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000}}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059519301657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059519301657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T09:46:04Z","timestamp":1695462364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059519301657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2590059519301657"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2019.09.004","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.xkme.2020.03.002","asserted-by":"object"}]},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Equivalent Efficacy and Decreased Rate of Overcorrection in Patients With Syndrome of Inappropriate Secretion of Antidiuretic Hormone Given Very Low-Dose Tolvaptan","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2019.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}